In vitro and in vivo evaluation of MHY908-loaded nanostructured lipid carriers for the topical treatment of hyperpigmentation

[1]  Seaung-youl Oh,et al.  Electroosmotic flow through skin: effect of current duration and poly(ethylene imine) , 2018, Journal of Pharmaceutical Investigation.

[2]  M. Zarrintan,et al.  Nanostructured Lipid Carrier for Topical Application of N-Acetyl Glucosamine. , 2016, Advanced pharmaceutical bulletin.

[3]  Y. Sumirtapura,et al.  Formulation, Characterisation, and in Vitro Skin Diffusion of Nanostructured Lipid Carriers for Deoxyarbutin Compared to a Nanoemulsion and Conventional Cream , 2016, Scientia pharmaceutica.

[4]  C. Nastruzzi,et al.  Encapsulation of cannabinoid drugs in nanostructured lipid carriers. , 2016, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[5]  S. Ghanbarzadeh,et al.  Enhanced stability and dermal delivery of hydroquinone using solid lipid nanoparticles. , 2015, Colloids and surfaces. B, Biointerfaces.

[6]  K. Adibkia,et al.  A comparative histological study on the skin occlusion performance of a cream made of solid lipid nanoparticles and Vaseline , 2015, Research in pharmaceutical sciences.

[7]  Tarek A. Ahmed,et al.  Utilization of nanotechnology to enhance percutaneous absorption of acyclovir in the treatment of herpes simplex viral infections , 2015, International journal of nanomedicine.

[8]  Il Kim,et al.  Nitric oxide-releasing poly(lactic-co-glycolic acid)-polyethylenimine nanoparticles for prolonged nitric oxide release, antibacterial efficacy, and in vivo wound healing activity , 2015, International journal of nanomedicine.

[9]  H. Jeong,et al.  Inhibition of melanogenesis by 2-[4-(5-chlorobenzo[d]thiazol-2-yl)phenoxy]-2-methylpropanoic acid (MHY908) , 2015, Archives of pharmacal research.

[10]  P. Campolongo,et al.  Cannabinoid antagonist in nanostructured lipid carriers (NLCs): design, characterization and in vivo study. , 2015, Materials science & engineering. C, Materials for biological applications.

[11]  Daeui Park,et al.  Potent Anti-Diabetic Effects of MHY908, a Newly Synthesized PPAR α/γ Dual Agonist in db/db Mice , 2013, PloS one.

[12]  J. Paoli,et al.  Euromelanoma: a dermatology‐led European campaign against nonmelanoma skin cancer and cutaneous melanoma. Past, present and future , 2012, The British journal of dermatology.

[13]  G. Sandri,et al.  Resveratrol-loaded solid lipid nanoparticles versus nanostructured lipid carriers: evaluation of antioxidant potential for dermal applications , 2012, International journal of nanomedicine.

[14]  D. Fisher,et al.  Key discoveries in melanocyte development. , 2011, The Journal of investigative dermatology.

[15]  Connie B. Lin,et al.  The role of keratinocyte growth factor in melanogenesis: a possible mechanism for the initiation of solar lentigines , 2009, Experimental dermatology.

[16]  R. Randall Wickett,et al.  Mechanisms Regulating Skin Pigmentation: The Rise and Fall of Complexion Coloration , 2009, International journal of molecular sciences.

[17]  J. Pardeike,et al.  Lipid nanoparticles (SLN, NLC) in cosmetic and pharmaceutical dermal products. , 2009, International journal of pharmaceutics.

[18]  R. Müller,et al.  Cetyl palmitate-based NLC for topical delivery of Coenzyme Q(10) - development, physicochemical characterization and in vitro release studies. , 2007, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[19]  J. Pardeike,et al.  Nanostructured lipid carriers (NLC) in cosmetic dermal products. , 2007, Advanced drug delivery reviews.

[20]  H. Korting,et al.  Lipid nanoparticles for improved topical application of drugs for skin diseases. , 2007, Advanced drug delivery reviews.

[21]  M. Ichihashi,et al.  Approaches to identify inhibitors of melanin biosynthesis via the quality control of tyrosinase. , 2007, The Journal of investigative dermatology.

[22]  Hyunsu Bae,et al.  Survey and mechanism of skin depigmenting and lightening agents , 2006, Phytotherapy research : PTR.

[23]  R. Müller,et al.  Polymorphic behaviour of Compritol®888 ATO as bulk lipid and as SLN and NLC , 2006, Journal of microencapsulation.

[24]  S. Jain,et al.  AOT water-in-oil microemulsions as a penetration enhancer in transdermal drug delivery of 5-fluorouracil. , 2005, Colloids and surfaces. B, Biointerfaces.

[25]  D. Tobin,et al.  Melanin pigmentation in mammalian skin and its hormonal regulation. , 2004, Physiological reviews.

[26]  R. Marks The stratum corneum barrier: the final frontier. , 2004, The Journal of nutrition.

[27]  R. Halder,et al.  Ethnic skin disorders overview. , 2003, Journal of the American Academy of Dermatology.

[28]  R. Müller,et al.  Solid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC) in cosmetic and dermatological preparations. , 2002, Advanced drug delivery reviews.

[29]  S. Wissing,et al.  Investigations on the occlusive properties of solid lipid nanoparticles (SLN). , 2001, Journal of cosmetic science.

[30]  I. Oh,et al.  Effects of non-ionic surfactants as permeation enhancers towards piroxicam from the poloxamer gel through rat skins. , 2001, International journal of pharmaceutics.

[31]  M. Eller,et al.  Mechanisms of Ultraviolet Light‐Induced Pigmentation , 1996, Photochemistry and photobiology.

[32]  Pey-Shiuan Wu,et al.  Formulation and Characterization of Hydroquinone Nanostructured Lipid Carriers by Homogenization Emulsification Method , 2017 .

[33]  Feng Zhang,et al.  Characterization of amorphous solid dispersions , 2017, Journal of Pharmaceutical Investigation.

[34]  R. Müller,et al.  Nanostructured Lipid Carriers (NLC): The Second Generation of Solid Lipid Nanoparticles , 2016 .

[35]  G. Prota,et al.  Melanins and melanogenesis , 1992 .

[36]  Zahra Tabbakhi,et al.  International Journal of Nanomedicine Dovepress Novel Formulation and Evaluation of a Q10-loaded Solid Lipid Nanoparticle Cream: in Vitro and in Vivo Studies , 2022 .